Healthcare
Galenica AG(GALNF)
Live Price
Offline$115.00
+0.00% today
1Y Change
+52.82%
Window
Jun 26, 2025 โ Jun 18, 2026
- Market Cap
- $4.10B
- Revenue Growth
- +5.5%
- EPS Growth
- -1.1%
- Dividend Yield
- 3.0%
Coverage: 251 bars ยท Jun 26, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Galenica AG (GALNF) is a Healthcare stock with a market cap of $4.10B and listed on OTC. The stock last traded around $115.00 and up 52.8% across the available one-year price window (Jun 26, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +5.5%, EPS growth of -1.1%, a dividend yield of 3.0%. What stands out right now is revenue +5.5%, EPS -1.1%, free cash flow +41.7% with operating margin 5.5% and ROIC 7.0%. The dividend matters to the case here, with a current yield around 3.0%. Valuation is more restrained than many high-expectation growth names at P/E 22.6 and price/sales 1.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines GALNF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+5.5% vs +7.6% peer median
Operating Margin
Below sector median
+5.5% vs +19.4% peer median
P/E
Below sector median
22.6 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report came in below the EPS bar
2026 was reported on Mar 10, 2026 with an EPS surprise of -6.4% and a revenue surprise of 0.0%.
The operating picture looks softer than before
Revenue is at +5.5% and EPS is at -1.1%, with operating margin around 5.5%.
The next real check-in already has a date
The next earnings event is scheduled for Aug 6, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Mar 10, 2026 | -6.4% | +0.0% | +0.0% | +0.0% |
2025 Mar 11, 2025 | +14.4% | +0.0% | +0.0% | +0.0% |
2024 Aug 6, 2024 | -6.4% | +0.0% | +0.0% | +0.0% |
Benchmark Edge
GALNF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
GALNF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
GALNF Max Drawdown
-1.02%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for GALNF and SPY.
Company Overview
Galenica AG
Other OTC
Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates 520 pharmacies, including 368 owned pharmacies and 152 partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also offers medication for treatment of patients at home; launches and distributes a portfolio of consumer health, pharmaceutical, and parapharmaceutical products; and marketing and sale services to partners in the healthcare market. The Logistics & IT segment provides range of specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers logistics and IT services, and master data system for the healthcare market; develops management solutions for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products, as well as complete management solutions for pharmacies. The company was founded in 1927 and is headquartered in Bern, Switzerland.
- Leadership
- Marc Werner
- IPO Date
- Jul 11, 2022
- Employees
- 4.5k
- Street Address
- Untermattweg 8
- Mailing
- Bern, 3027
- Region
- Bern, CH
- Reporting Currency
- USD
- Investor Line
- 41 58 852 81 11
- Last Updated
- Apr 29, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 22.6
- EV/EBITDA
- 14.5
- Price/Sales
- 1.0
- Price/Book
- 2.8
Growth
- Revenue
- +5.5%
- EPS
- -1.1%
- Free Cash Flow
- +41.7%
Profitability
- Gross Margin
- 10.1%
- Operating Margin
- 5.5%
- Net Margin
- 4.4%
- ROE
- 12.4%
- ROIC
- 7.0%
Balance Sheet
- Debt/Equity
- 0.72
- Current Ratio
- 1.15
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.